Citing concerns about mRNA technology, the Trump administration has pulled funding for a vaccine, even though Moderna says it ...

Patients with respiratory syncytial virus (RSV) hospitalization have increased odds of any acute cardiovascular event ...

A statewide immunization program for infants against respiratory syncytial virus (RSV), which began in 2024, has already ...

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

Universal immunisation with nirsevimab significantly reduces hospitalizations and paediatric intensive care admissions for ...

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...

The APA Formalized the February 2024 BioVaxys Acquisition of the Former IMV Inc. Assets VANCOUVER, BC, May 29, 2025 /PRNewswire/ ...

The new three-illness dashboard includes a history of outbreaks for any or all of the three respiratory illnesses. It ...

Adults with RSV-associated acute respiratory infection face a 2.7-fold higher risk for death within one year, according to a ...

Kennedy's move appears to shortcut the CDC's outside vaccine advisers, dropping COVID vaccines from the list recommended for ...